Supernus Pharmaceuticals, Inc. /
Sage Therapeutics, Inc.
Supernus Pharmaceuticals, Inc. completes purchase of Sage Therapeutics, Inc.




Source for the buyer and target: SUPERNUS PHARMACEUTICALS, INC.
For the buyer and target.
“Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”).”
Published 31 Jul 2025
Open the sourceWhat happened
Supernus Pharmaceuticals, Inc. completed its acquisition of Sage Therapeutics, Inc., according to a filing dated July 31, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Supernus Pharmaceuticals, Inc. completes purchase of Sage Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Supernus Pharmaceuticals, Inc. completes purchase of Sage Therapeutics, Inc. Supernus Pharmaceuticals, Inc. completed its acquisition of Sage Therapeutics, Inc., according to a filing dated July 31, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly